Thermodynamically stable ionic liquid microemulsions pioneer pathways for topical delivery and peptide application

Summary

This is a preclinical formulation study with mouse experiments, not a human trial. The authors note that GHK-Cu is hard to deliver through the skin, which limits non-invasive use as a hair growth promoter. To address this, they designed an ionic liquid–based microemulsion (IL-M) meant to carry more GHK-Cu into the skin while keeping the peptide active. They then tested the system in mice.

Key Findings

• The IL-M improved local delivery of GHK-Cu by about three-fold while retaining its biological function
• Experiments in mice were reported to validate the effectiveness of the IL-M system
• The authors examined the system’s effects on growth factors such as vascular endothelial growth factor (VEGF)
• The microemulsion increased activation of the Wnt/β-catenin signaling pathway, which includes factors involved in hair growth regulation
• The authors describe the system as safe and non-invasive, with potential for treating hair loss

Methodology

The microemulsion was designed using theoretical calculations and pseudo-ternary phase diagrams. It combines the high drug solubility of ionic liquids with the skin permeability of microemulsions. Delivery and biological effects were then tested in mice.

Limitations

• Animal (mouse) study only: no human data
• The abstract does not give hair growth measurements, group sizes, doses, or treatment length
• The abstract compares GHK-Cu with minoxidil and finasteride only as background; those drugs were not reported as tested comparators
• The main focus is the delivery vehicle, so results depend on this specific formulation and may not apply to other GHK-Cu products

Relevance to Content

This paper supports GHK-Cu hair growth claims only at the preclinical level. It shows that topical delivery is a real hurdle and that formulation matters. Do not present it as evidence that GHK-Cu regrows hair in people.

See Also

• Parent compound: GHK-Cu
• GHK